XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.2
Collaboration and License Agreements - Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Disaggregation of Revenue [Line Items]        
Revenue $ 15,825 $ 32,412 $ 224,638 $ 211,656
GSK        
Disaggregation of Revenue [Line Items]        
Revenue 277 0 29,600 120,000
Horizon        
Disaggregation of Revenue [Line Items]        
Revenue 1,539 6,666 23,206 21,251
Takeda        
Disaggregation of Revenue [Line Items]        
Revenue 14,009 25,507 146,477 67,100
Janssen        
Disaggregation of Revenue [Line Items]        
Revenue 0 239 355 3,305
Amgen        
Disaggregation of Revenue [Line Items]        
Revenue $ 0 $ 0 $ 25,000 $ 0